A path to improved pharmaceutical productivity

Nature Reviews Drug Discovery

Volumn 2, Issue 9, 2003, Pages 751-753

  Cohen, Carl M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG RESEARCH; FINANCIAL MANAGEMENT; METRIC SYSTEM; PHARMACOLOGICAL PARAMETERS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY CONTROL; METHODOLOGY; PHARMACEUTICS;

TECHNOLOGY, PHARMACEUTICAL;

EID: 0142089831     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1180     Document Type: Article

References (9)

1. Grabowski, H., Vernon, J. & Di Masi, J. A. Returns on research and development for 1990s new drug introductions. Pharamcogenomics 20, S11-S29 (2002).
2. DiMasi, J. A. The value of improving the productivity of the drug development process: faster times and better decisions. Pharmacogenomics 20, S1-S10 (2002).
3. Sim, P. & Gill, J. Results of the 2002 Drug Discovery Performance Metrics Survey (CMR International, Epsom, UK, 2003).
4. CHI Strategies to Optimize R&D Performance, June 9-19, Philadelphia, Pennsylvania, USA (2003).
5. Phacilitate, Inc. R&D Leaders Forum. October, Geneva, Switzerland (2003).
6. IBC Drug Discovery Technology Conference, August 10-15, Boston, Massachusetts, USA (2003).
7. Parexels Pharmaceutical R&D Statistical Sourcebook 2002/2003 (Parexel International, Waltham, USA, 2003).
8. A Revolution in R&D: How Genomics and Genetics are Transforming the Biopharmaceutical Industry (Boston Consulting Group, Boston, USA 2001).
9. Pharma 2010: The Threshold of Innovation (IBM Business Consulting Services, Armonk, USA, 2002).